AI assistant
Sending…
EXELIXIS, INC. — Director's Dealing 2019
May 23, 2019
30561_dirs_2019-05-22_543cd284-8d9e-47dd-b6c8-3621cbe61f55.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-05-21
Reporting Person: SCANGOS GEORGE A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-21 | Common Stock | M | 15000 | $4.57 | Acquired | 1248031 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-21 | Option (right to buy) | $4.57 | M | 15000 | Disposed | 2019-05-23 | Common Stock (15000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8963 | Indirect |
| Common Stock | 8963 | Indirect |
| Common Stock | 5669 | Indirect |
Footnotes
F1: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
F2: Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 20, 2019.
F4: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012.
More from EXELIXIS, INC.
Regulatory Filings
2026
May 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 21